Trial intelligence / Profile preview

Effect of Sodium Hypochlorite 0.005% in Treatment of Acne

IRCT20200701047976N1Phase 3Completed

Sponsor
Shiraz University of Medical Sciences
Start
Jul 2020
Modality
Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3 trial of sodium hypochlorite in acne vulgaris, sponsored by Shiraz University of Medical Sciences. Started Jul 2020; status: completed.

02

Drugs

sodium hypochlorite
03

Conditions

acne vulgaris

Beyond the preview

Go deeper on IRCT20200701047976N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20200701047976N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call